{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04677153",
            "orgStudyIdInfo": {
                "id": "IRB00265240"
            },
            "organization": {
                "fullName": "Johns Hopkins University",
                "class": "OTHER"
            },
            "briefTitle": "Rapid HCV Treatment Access for Persons Who Use Drugs",
            "officialTitle": "Rapid HCV Test and Treat to Increase HCV Treatment Uptake Among People Who Use Drugs",
            "acronym": "RAPID-HCV",
            "therapeuticArea": [
                "Gastroenterology"
            ],
            "study": "rapid-hcv-treatment-access-for-persons-who-use-drugs"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-08-06",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-12-17",
            "studyFirstSubmitQcDate": "2020-12-17",
            "studyFirstPostDateStruct": {
                "date": "2020-12-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-11-08",
            "lastUpdatePostDateStruct": {
                "date": "2023-11-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Johns Hopkins University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "AbbVie",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is being done to compare two strategies to deliver HCV treatment to persons with hepatitis C virus (HCV) who also use drugs and are participating in an outpatient opioid treatment program (OTP). Participants will be randomized into one of two treatment groups:\n\n1. Test and treat plus peer-mentors: This treatment group will be offered 8 weeks of glecaprevir/pibrentasvir (an FDA approved HCV treatment) within days of HCV diagnosis at the OTP. Participants in this group will receive treatment adherence support from a peer-mentor who is someone who has been cured of HCV infection.\n2. Standard of care HCV treatment referral: This treatment group will be referred to an offsite HCV treatment location. This is the usual care for anyone who tests positive for HCV at the OTP who is not participating in this study."
        },
        "conditionsModule": {
            "conditions": [
                "Hepatitis C Virus Infection, Response to Therapy of"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 124,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Test and Treat plus Peer Mentors Intervention Arm",
                    "type": "EXPERIMENTAL",
                    "description": "Participants offered 8 weeks of glecaprevir/pibrentasvir (GLE/PIB) at OTP plus peer support.",
                    "interventionNames": [
                        "Other: Test and treat plus peer mentors"
                    ]
                },
                {
                    "label": "Standard of Care Referral Arm",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants referred to offsite (non-OTP) location for HCV treatment.",
                    "interventionNames": [
                        "Other: Usual care"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Test and treat plus peer mentors",
                    "description": "Rapid start of HCV treatment at OTP within days of HCV diagnosis. Participants will receive 8 weeks of glecaprevir/pibrentasvir and will work with a peer mentor during and after treatment.",
                    "armGroupLabels": [
                        "Test and Treat plus Peer Mentors Intervention Arm"
                    ],
                    "otherNames": [
                        "On-site treatment with peer support HCV treatment implementation strategy"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Usual care",
                    "description": "Participants are referred to another location for HCV treatment.",
                    "armGroupLabels": [
                        "Standard of Care Referral Arm"
                    ],
                    "otherNames": [
                        "Standard of care referral HCV treatment implementation strategy"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Participants Who Initiate HCV Therapy",
                    "description": "Proportion of participants who start HCV treatment in each arm.",
                    "timeFrame": "Within 12 weeks of randomization"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "HCV Treatment Completion",
                    "description": "Proportion of participants who start HCV treatment and subsequently complete treatment (take more than 90% of prescribed treatment course).",
                    "timeFrame": "At expected end of treatment date, up to 20 weeks"
                },
                {
                    "measure": "Sustained Virologic Response (SVR) Following Treatment by Intervention Group",
                    "description": "Proportion of participants in each arm who achieved SVR, defined as HCV RNA \\<15 IU/mL between 10 and 36 weeks weeks after completion of the HCV treatment regimen.",
                    "timeFrame": "Post-treatment week 12"
                },
                {
                    "measure": "Time to HCV Treatment Initiation",
                    "description": "Time to HCV Treatment Initiation in weeks.",
                    "timeFrame": "From randomization to initiation of treatment, up to 36 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Ability and willingness of participant to provide written informed consent\n* Men and women age \u226518 to \u226470 years at study entry\n* HCV antibody positive/detectable HCV RNA\n* HCV treatment na\u00efve (no prior treatment with an approved or investigational oral DAA therapy)\n* Negative pregnancy test at screening or at the day of treatment initiation (females of childbearing potential only)\n* If co-infection with Human Immunodeficiency Virus (HIV) is documented, the subject must be anti-retroviral treatment (ART) na\u00efve with CD4 T cell count \\>500 cells/mm3 OR on a stable ART regimen (containing only permissible ART - Raltegravir; dolutegravir; Rilpivirine; Elvitegravir/cobicistat; Tenofovir disoproxil fumarate; Tenofovir alafenamide; Emtricitabine; Lamivudine and/or Abacavir, bictegravir)\n\nExclusion Criteria:\n\n* Women who are pregnant or breastfeeding, or considering becoming pregnant during the study and for 30 days after the last dose of study drug\n* Known allergy/sensitivity or any hypersensitivity to components of study drugs or their formulation\n* Current or history of decompensated liver disease (including but not limited to encephalopathy, variceal bleeding, or ascites) prior to study entry\n* History of hepatocellular carcinoma (HCC)\n* Any history of active Hepatitis B or positive HBsAg test\n* Platelet count \\< 150,000/mm3\n* HCV RNA undetectable\n* History of clinically significant abnormalities or co-morbidities that make the subject an unsuitable candidate for this study, in the opinion of the investigator.\n* Women of childbearing potential that are not practicing at least one specified method of birth control that is effective from Study Day 1 through at least 30 days after the last dose of study drug.\n* Subject is currently taking any of the following prohibited medications: red yeast rice (monacolin K), St. John's Wort, carbamazepine, dabigatran, efavirenz, phenytoin, pentobarbital, phenobarbital, primidone, rifabutin, rifampin.\n* Subject is not able or willing to safely discontinue the prohibited medications or supplements listed below at least 14 days prior to the first dose of GLE/PIB: some HMG-CoA reductase inhibitors, astemizole, cisapride, terfenadine, ethinyl estradiol.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Oluwaseun Falade-Nwulia, MBBS, MPH",
                    "role": "CONTACT",
                    "phone": "4422871964",
                    "email": "ofalade1@jhmi.edu"
                },
                {
                    "name": "Mark Sulkowski, MD",
                    "role": "CONTACT",
                    "phone": "410-955-7538"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Oluwaseun Falade-Nwulia, MBBS, MPH",
                    "affiliation": "Johns Hopkins University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Alabama",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35294",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ricardo Franco, MD",
                            "role": "CONTACT",
                            "email": "rfranco@uabmc.edu"
                        },
                        {
                            "name": "Ricardo Franco, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                },
                {
                    "facility": "University of California, San Francisco",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94143",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jennifer Price, MD, PhD",
                            "role": "CONTACT",
                            "email": "Jennifer.Price@ucsf.edu"
                        },
                        {
                            "name": "Jennifer Price, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Johns Hopkins University",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21287",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Oluwaseun Falade-Nwulia, MBBS, MPH",
                            "role": "CONTACT",
                            "email": "ofalade1@jhmi.edu"
                        },
                        {
                            "name": "Oluwaseun Falade-Nwulia, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "University Health Network Toronto",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M5G 2C4",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Jordan Feld, MD, MPH",
                            "role": "CONTACT",
                            "email": "Jordan.Feld@uhn.ca"
                        },
                        {
                            "name": "Jordan Feld, MD, MPH",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006526",
                    "term": "Hepatitis C"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006505",
                    "term": "Hepatitis"
                },
                {
                    "id": "D000008107",
                    "term": "Liver Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000086982",
                    "term": "Blood-Borne Infections"
                },
                {
                    "id": "D000003141",
                    "term": "Communicable Diseases"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000006525",
                    "term": "Hepatitis, Viral, Human"
                },
                {
                    "id": "D000014777",
                    "term": "Virus Diseases"
                },
                {
                    "id": "D000018178",
                    "term": "Flaviviridae Infections"
                },
                {
                    "id": "D000012327",
                    "term": "RNA Virus Infections"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9592",
                    "name": "Hepatitis A",
                    "relevance": "LOW"
                },
                {
                    "id": "M9591",
                    "name": "Hepatitis",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17522",
                    "name": "Virus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9611",
                    "name": "Hepatitis C",
                    "asFound": "Hepatitis C Virus Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11107",
                    "name": "Liver Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2593",
                    "name": "Blood-Borne Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M9610",
                    "name": "Hepatitis, Viral, Human",
                    "relevance": "LOW"
                },
                {
                    "id": "M20324",
                    "name": "Flaviviridae Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M15149",
                    "name": "RNA Virus Infections",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        }
    },
    "hasResults": false
}